Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- LP.8.1-Adapted Novavax COVID Vaccine Filed in Japan: Takeda
June 30, 2025
- Fuji Pharma Filed for OTC Approval of Emergency Contraceptive Last October
June 27, 2025
- Chugai Files Alecensa for ALK-Positive Solid Tumors in Japan
June 27, 2025
- Kyowa Kirin Wins Japan Nod for Lumicef Pen Injector
June 27, 2025
- ASKA Launches Japan PIII of Relugolix Combo for Endometriosis
June 26, 2025
- Japan Approves Crysvita Prefilled Syringe: Kyowa Kirin
June 26, 2025
- SanBio Pushes Back Shipment Approval Timeline for Cell Therapy Akuugo
June 26, 2025
- Takeda Zeros in on US Successor Ahead of 2026 CEO Transition
June 26, 2025
- Japan Pharma Market to Reach 12.28 Trillion Yen by FY2029: IQVIA
June 25, 2025
- Novartis Taps Cancer Institute Hospital as Priority Trial Site in Japan
June 25, 2025
- FDA Approves Daiichi’s Datroway for EGFR Lung Cancer
June 25, 2025
- Medipal/JCR’s MPS IIIB Therapy Earns Orphan Status in Europe
June 25, 2025
- Aculys Moves Toward First Launch as It Tackles Japan’s Drug Lag/Loss
June 24, 2025
- Axcelead, Superluminal Pair Up to Target Challenging Molecular Mechanisms
June 24, 2025
- Otsuka Bags Rights to Bispecific T-Cell Engager from China’s Harbour
June 24, 2025
- Ono Snags Japan, Korea Rights to Vertex’s Povetacicept
June 24, 2025
- GMP Deviation at CMO Katsuyama Caused Viatris Shipment Halt
June 23, 2025
- Boehringer to Invest 300 Million Euros in New Facilities at Yamagata Plant
June 23, 2025
- GSK’s RSV Vaccine Arexvy Filed for High-Risk Adults Aged 18-49 in Japan
June 23, 2025
- Moderna Files Next-Gen COVID Vaccine in Japan
June 23, 2025
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…